BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11521203)

  • 1. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression.
    Soucek T; Rosner M; Miloloza A; Kubista M; Cheadle JP; Sampson JR; Hengstschläger M
    Oncogene; 2001 Aug; 20(35):4904-9. PubMed ID: 11521203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.
    Rosner M; Freilinger A; Hengstschläger M
    Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
    Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
    Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.
    Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
    Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell cycle and tuberous sclerosis.
    Hengstschläger M; Rosner M
    Prog Cell Cycle Res; 2003; 5():43-8. PubMed ID: 14593699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.
    Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
    Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tuberous sclerosis genes, TSC1 and TSC2, trigger different gene expression responses.
    Rosner M; Freilinger A; Lubec G; Hengstschläger M
    Int J Oncol; 2005 Nov; 27(5):1411-24. PubMed ID: 16211238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
    Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA
    Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation screening of the entire coding regions of the TSC1 and the TSC2 gene with the protein truncation test (PTT) identifies frequent splicing defects.
    Mayer K; Ballhausen W; Rott HD
    Hum Mutat; 1999; 14(5):401-11. PubMed ID: 10533066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients.
    Goedbloed MA; Nellist M; Verhaaf B; Reuser AJ; Lindhout D; Sunde L; Verhoef S; Halley DJ; van den Ouweland AM
    Eur J Hum Genet; 2001 Nov; 9(11):823-8. PubMed ID: 11781698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38.
    Rosner M; Hofer K; Kubista M; Hengstschläger M
    Oncogene; 2003 Jul; 22(31):4786-98. PubMed ID: 12894220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberin activates the proapoptotic molecule BAD.
    Freilinger A; Rosner M; Krupitza G; Nishino M; Lubec G; Korsmeyer SJ; Hengstschläger M
    Oncogene; 2006 Oct; 25(49):6467-79. PubMed ID: 16702951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.
    Benvenuto G; Li S; Brown SJ; Braverman R; Vass WC; Cheadle JP; Halley DJ; Sampson JR; Wienecke R; DeClue JE
    Oncogene; 2000 Dec; 19(54):6306-16. PubMed ID: 11175345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
    Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
    Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
    Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteins interacting with the tuberous sclerosis gene products.
    Rosner M; Freilinger A; Hengstschläger M
    Amino Acids; 2004 Oct; 27(2):119-28. PubMed ID: 15351877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis.
    Niida Y; Lawrence-Smith N; Banwell A; Hammer E; Lewis J; Beauchamp RL; Sims K; Ramesh V; Ozelius L
    Hum Mutat; 1999; 14(5):412-22. PubMed ID: 10533067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel TSC2 mutations and decreased expression of tuberin in cultured tumor cells with an insertion mutation.
    Feng JH; Yamamoto T; Nanba E; Ninomiya H; Oka A; Ohno K
    Hum Mutat; 2004 Apr; 23(4):397. PubMed ID: 15024740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.